Navigated to Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease
Get the app

Log in
The Long Run with Luke Timmerman

Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease

December 15
1h 7m

View Transcript

Episode Description

Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).
See all episodes

Never lose your place, on any device

Create a free account to sync, back up, and get personal recommendations.

Create account